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A 48-year-old male patient diagnosed with Kawasaki disease in childhood presented with recurrent angina afer  
undergoing coronary artery bypass surgery in 1996. Percutaneous transluminal coronary angioplasty and 
intracoronary stent placement to a lesion in the proximal ramus intermedius were performed successfully. This 
case illustrates the complementary nature of percutaneous and surgical myocardial revascularization strategies 
in appropriately selected patients with Kawasaki disease. (J Interven Cardiol2002; 1529-32) 
Case Report 
A 48-year-old male with a past medical history of 
Kawasaki disease diagnosed in childhood was referred 
for cardiac catheterization for recurrent angina and ab- 
normal myocardial perfusion study. Prior cardiovascu- 
lar history was significant for two anterior wall my- 
ocardial infarctions in 1987, followed by coronary 
artery bypass grafting (CABG) in 1996. Surgery con- 
sisted of left internal mammary artery (IMA) graft to 
the left anterior descending (LAD) artery, saphenous 
vein graft to the first diagonal artery, saphenous vein 
graft to the first obtuse marginal artery, and saphenous 
vein graft to the right posterior descending artery. 
In July 1998, the patient suffered an inferior wall 
myocardial infarction treated with angioplasty and 
stent placement to the saphenous vein graft supplying 
the right posterior descending artery. The procedure 
was uneventful, and he was discharged in stable con- 
dition. In February 1999, he developed recurrent 
angina pectoris, which led to intensification of his 
medical therapy and performance of gated Sestamibi 
single photon emission computed tomography 
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(SPECT). Myocardial perfusion images revealed re- 
versible, moderate-sized lateral and large inferior de- 
fects consistent with ischemia, as well as a large fixed 
anterior defect consistent with prior infarction. Gated 
SPECT analysis revealed an ejection fraction of 37% 
with mid-anterior wall dyskinesis and apical hypoki- 
nesis. Cardiac catheterization was recommended. 
Cardiac catheterization showed severe three vessel 
native coronary artery disease (CAD) consisting of an 
occluded proximal right coronary artery (RCA) and 
first obtuse marginal branch, an 80% to 90% proximal 
ramus intermedius stenosis, and a 50% to 60% proxi- 
mal LAD stenosis. Multiple coronary aneurysms were 
present in the proximal segments (Fig. 1). Of the by- 
pass grafts, the left IMA graft to the LAD artery was 
100% occluded; the saphenous vein graft to the first 
diagonal artery had a 50% to 60% mid-stenosis as well 
as a 50% to 60% anastomotic stenosis. The saphenous 
vein graft to the right posterior descending artery was 
patent. Because of his recurrent angina pectoris and 
abnormal myocardial SPECT, coronary revasculariza- 
tion (redo-CABG versus percutaneous coronary inter- 
vention [PCI]) was recommended, and the patient was 
scheduled for PCI. Percutaneous transluminal coro- 
nary angioplasty (PTCA) of the ramus intermedius 
was performed using an 8Fr EBU guide catheter, a 
0.014" ACS Hi-Torque Floppy guidewire (Advanced 
Cardiovascular Systems Inc., Temecula, CA, USA), 
and a 2.5 X 15 mm SCIMED Coyote balloon (Scimed 
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Figure 1. Right anterior oblique (RAO) cranial projection of the 
left coronary artery showing the stenosis in the proximal ramus 
intermedius (arrow) and multiple aneurysms in the left anterior 
descending artery. 
Life Systems Inc., Maple Grove, MN, USA). Subse- 
quently, the guidewire was exchanged for a 0.014" 
Medtronic Mustang floppy guidewire (Medtronic Inc., 
Minneapolis, MN. USA), and a 2.5 X 8 mm ACS 
Multi-link Duet stent was deployed across the lesion 
and postdilated using a 3.0 X 10 mm SCIMED NC 
Figure 2. Right anterior oblique (RAO) cranial projection of the 
left coronary artery after stent deployment and optimization in the 
proximal ramus intermedius (arrow). 
Bandit balloon. Final angiography revealed no resid- 
ual stenosis, no dissection, and thrombolysis in my- 
ocardial infarction (TIMI) 111 flow (Fig. 2). The patient 
was discharged to home the following day on clopido- 
grel75 mg daily as well as his other medications. 
Discussion 
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Mucocutaneous lymph node syndrome, or 
Kawasaki disease, was first described in Japan in 1967 
as a generalized vasculitis of unclear etiology. Re- 
cently, evidence supports a role for superantigens, 
which induce extensive T cell proliferation and cy- 
tokine production, in the pathogenesis of the disease.' 
While the acute inflammatory syndrome is generally 
self-limited, long-term morbidity and mortality is due 
almost exclusively to the cardiovascular sequelae.* 
Coronary aneurysms occur in approximately 25% of 
untreated patients during the acute phase and are more 
frequent in young children, males, and those not 
treated with intravenous immunoglobulin. The major- 
ity of these aneurysms do show regression towards 
normal within a 5-year period; unfortunately, resolu- 
tion of aneurysms can lead to vessel obstruction or 
sten~sis.~ Nonetheless, it is estimated that stenotic le- 
sions will develop in approximately 19% of all cases 
with coronary aneurysms and 46% of those with giant 
(> 8 mm) aneurysms! 
Treatment of ischemic coronary heart disease re- 
sulting from Kawasaki disease has been controversial. 
While medical therapy remains the mainstay of treat- 
ment for this disease, surgical and percutaneous revas- 
cularization strategies have been explored as options 
for the amelioration of symptoms and to reduce car- 
diovascular morbidity and mortality. Kitamura et al. 
reported long-term follow-up data on a group of 168 
patients who underwent surgical revascularization for 
ischemic sequelae of Kawasaki disease, and concluded 
that patients who received IMA grafts had signifi- 
cantly improved graft patency rates and significantly 
increased long-term survival rates when compared 
with patients who received saphenous vein grafts 
only.5 Interestingly, our patient demonstrated early 
failure of the IMA graft to the LAD coronary artery, 
possibly because the stenosis demonstrated in his LAD 
was not critical in nature. Others have reported success 
with conventional balloon angioplasty for stenoses as- 
sociated with Kawasaki disease.6s7 Unsuccessful at- 
tempts at balloon angioplasty for the treatment of these 
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lesions also has been reported.8 More recently, Sug- 
imura et al. reported success using rotational atherec- 
tomy to treat heavily calcified stenoses that had not re- 
sponded to conventional balloon angioplasty .' How- 
ever, their finding that coronary aneurysms developed 
late in two of the four patients treated raises concerns 
regarding the long-term safety of this treatment modal- 
ity. 
There have been a few recent reports in the literature 
of successful stent placement for coronary artery 
stenoses as sequelae of Kawasaki disease.I0-'* In 
1997, Hijazi et al. described the first reported instance 
of stent implantation in a 16-year-old female with an 
80% LAD stenosis that demonstrated dissection after 
balloon angioplasty." One year later, Ishii et al. de- 
scribed the utility of intravascular ultrasound in order 
to exclude heavy calcification and thus permit suc- 
cessful stent implantation for five out of six children 
presenting with lesions of the LAD or right coronary 
arteries." More recently, Hashmi et al. described suc- 
cessful stent placement into an occluded LAD in a 10- 
year-old child with chest pain and an abnormal my- 
ocardial perfusion study. Twelve-month follow-up an- 
giography demonstrated only mild in-stent intimal 
proliferation." Finally, Ueno et al. reported on stent 
implantation for a stenotic as well as aneurysmal coro- 
nary artery in a patient with Kawasaki disease.13 They 
deployed a 4.5 mm stent in the mid-RCA of a patient 
who had thrombotic occlusion of the vessel and had al- 
ready sustained three non-Q wave myocardial infarc- 
tions to the inferior wall. The treated artery appeared 
markedly ectatic throughout, whereas the vessel 
treated in our case contained a discrete aneurysmal 
segment immediately proximal to the stenotic region, 
which was of normal caliber. We were especially care- 
ful to deploy the stent so that the proximal edge was 
not hanging out into the aneurysm, but rather just cov- 
ered the stenotic portion of the vessel. We also decided 
to treat the patient with aspirin and clopidogrel indefi- 
nitely in order to prevent stent thrombosis as well as 
thrombosis within the aneurysmal segments. Six 
months following stent placement, the patient remains 
clinically improved with respect to anginal symptoms 
and stable at follow-up visits. 
Conclusion 
Intracoronary stent placement should be considered 
as an adjunct or an alternative to other revasculariza- 
tion strategies in the management of patients with is- 
chemic sequelae of Kawasaki disease. Stent placement 
may offer advantages over conventional balloon an- 
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